 | Up a level |
Velayutham, Naveen Kumar and Thamaraikani, Tamilanban and Wahab, Shadma and Khalid, Mohammad and Gobinath, Ramachawolran and Abullais, Shahabe Saquib and Wong, Ling Shing and Mahendran, Sekar and Gan, Siew Hua and Ebenezer, Angel Jemima and Ravikumar, Mrinalini and Vetriselvan, Subramaniyan * and Nur Najihah, Izzati Mat Rani and Wu, Yuan Seng * and Jeyabalan, Srikanth (2024) Corrigendum: Stylopine: a potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy. Frontiers in Pharmacology, 15. ISSN 1663-9812
Muhamad Azrul, Amir Yusri and Mahendran, Sekar and Wong, Ling Shing and Gan, Siew Hua and Ravi, Subban and Vetriselvan, Subramaniyan and Nur Najihah, Izzati Mat Rani and Chidambaram, Kumarappan and Begum, M Yasmin and Ramar, Mohankumar and Sher Zaman, Safi and Siddharthan, Selvaraj and Wu, Yuan Seng * and Revathy, Palanisamy and Fuloria, Shivkanya and Fuloria, Neeraj Kumar and Lum, Pei Teng and Sinouvassane, Djearamane (2023) Celastrol: A Potential Natural Lead Molecule for New Drug Design, Development and Therapy for Memory Impairment. Drug Design, Development and Therapy, 17. ISSN 1177-8881
Lum, Pei Teng and Mahendran, Sekar and Seow, Lay Jing and Shaikh, Mohd Farooq and Alina, Arulsamy and Thaarvena, Retinasamy and Gan, Siew Hua and Gnanaraj, Charles and Norhaizan, Mohd Esa and Gobinath, Ramachawolran and Vetriselvan, Subramaniyan and Chinni, Suresh V and Wu, Yuan Seng * (2023) Neuroprotective potency of mangiferin against 3-nitropropionic acid induced Huntington’s disease-like symptoms in rats: possible antioxidant and anti-inflammatory mechanisms. Frontiers in Pharmacology, 14. ISSN 1663-9812
Subramanian, Arunkumar and Tamilanban, T and Mahendran, Sekar and Begum, M Yasmin and Atiya, Akhtar and Gobinath, Ramachawolran and Wong, Ling Shing and Subramaniyan, Vetriselvan and Gan, Siew Hua and Nur Najihah, Izzati Mat Rani and Wu, Yuan Seng * and Chinni, Suresh V and Fuloria, Shivkanya and Fuloria, Neeraj Kumar (2023) Neuroprotective potential of Marsilea quadrifolia Linn against monosodium glutamate-induced excitotoxicity in rats. Frontiers in Pharmacology, 14. ISSN 1663-9812
Dayang Nooreffazleen, Yahya and Rhanye, Mac Guad and Wu, Yuan Seng * and Gan, Siew Hua and Subash, C.B. Gopinath and Hasif, Adlli Zakariah and Rusdi, Abdul Rashid and Maw, Shin Sim (2023) SLC1A2 Gene Polymorphism Influences Methamphetamine-Induced Psychosis. Journal of Personalized Medicine, 13 (2). ISSN 2075-4426
Velayutham, Naveen Kumar and Thamaraikani, Tamilanban and Wahab, Shadma and Khalid, Mohammad and Gobinath, Ramachawolran and Abullais, Shahabe Saquib and Wong, Ling Shing and Mahendran, Sekar and Gan, Siew Hua and Ebenezer, Angel Jemima and Ravikumar, Mrinalini and Subramaniyan, Vetriselvan and Nur Najihah, Izzati Mat Rani and Wu, Yuan Seng * and Jeyabalan, Srikanth (2023) Stylopine: A potential natural metabolite to activate vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy. Frontiers in Pharmacology, 14. ISSN 1663-9812
Fuloria, Shivkanya and Sekar, Mahendran and Farrah Syazaba, Khattulanuar and Gan, Siew Hua and Nur Najihah, Izzati Mat Rani and Ravi, Subban and Vetriselvan, Subramaniyan and Jeyabalan, Srikanth and Begum, M Yasmin and Chidambaram, Kumarappan and Kathiresan, V Sathasivam and Sher Zaman, Safi and Wu, Yuan Seng * and Rusli, Bin Nordin and Mohammad Nazmul, Hasan Mazia and Vinoth, Kumarasamy and Lum, Pei Teng and Fuloria, Neeraj Kumar (2022) Chemistry, Biosynthesis and Pharmacology of Viniferin: Potential Resveratrol-Derived Molecules for New Drug Discovery, Development and Therapy. Molecules, 27 (16). ISSN 1420-3049
Fuloria, Shivkanya and Muhamad Azrul, Amir Yusri and Mahendran, Sekar and Gan, Siew Hua and Nur Najihah, Izzati Mat Rani and Lum, Pei Teng and Ravi, Subban and Vetriselvan, Subramaniyan and Abul Kalam, Azad and Jeyabalan, Srikanth and Wu, Yuan Seng * and Meenakshi, Dhanalekshmi Unnikrishnan and Kathiresan, V Sathasivam and Fuloria, Neeraj Kumar (2022) Genistein: A Potential Natural Lead Molecule for New Drug Design and Development for Treating Memory Impairment. Molecules, 27 (1). ISSN 1420-3049
Naurah, Nabihah Nasir and Mahendran, Sekar and Fuloria, Shivkanya and Gan, Siew Hua and Nur Najihah, Izzati Mat Rani and Ravi, Subban and Begum, M Yasmin and Chidambaram, Kumarappan and Kathiresan, V Sathasivam and Jeyabalan, Srikanth and Dhiravidamani, Arulmozhi and Thangavelu, Lakshmi and Lum, Pei Teng and Vetriselvan, Subramaniyan and Wu, Yuan Seng * and Abdul Kalam, Azad and Fuloria, Neeraj Kumar (2022) Kirenol: A Potential Natural Lead Molecule for a New Drug Design, Development, and Therapy for Inflammation. Molecules, 27 (3). ISSN 1420-3049
Nurul Amirah, Mohd Zaid and Mahendran, Sekar and Bonam, Srinivasa Reddy and Gan, Siew Hua and Lum, Pei Teng and Begum, M Yasmin and Nur Najihah, Izzati Mat Rani and Vaijanathappa, Jaishree and Wu, Yuan Seng * and Vetriselvan, Subramaniyan and Fuloria, Neeraj Kumar and Fuloria, Shivkanya (2022) Promising Natural Products in New Drug Design, Development, and Therapy for Skin Disorders: An Overview of Scientific Evidence and Understanding Their Mechanism of Action. Drug Design, Development and Therapy, 16. pp. 23-66. ISSN 1177-8881
Lum, Pei Teng and Mahendran, Sekar and Gan, Siew Hua and Jeyabalan, Srikanth and Bonam, Srinivasa Reddy and Nur Najihah, Izzati Mat Rani and Ku-Marina, Ku-Mahdzir and Seow, Lay Jing and Wu, Yuan Seng * and Vetriselvan, Subramaniyan and Fuloria, Neeraj Kumar and Fuloria, Shivkanya (2022) Therapeutic potential of mangiferin against kidney disorders and its mechanism of action: A review. Saudi Journal of Biological Sciences, 29 (3). pp. 1530-1542. ISSN 1319-562X
Farrah, Syazana Khattulanuar and Mahendran, Sekar and Fuloria, Shivkanya and Gan, Siew Hua and Nur Najihah, Izzati Mat Rani and Ravi, Subban and Chidambaram, Kumarappan and Begum, M Yasmin and Abdul Kalam, Azad and Jeyabalan, Srikanth and Dhiravidamani, Arulmozhi and Thangavelu, Lakshmi and Lum, Pei Teng and Vetriselvan, Subramaniyan and Wu, Yuan Seng * and Kathiresan, V Sathasivam and Fuloria, Neeraj Kumar (2022) Tilianin: A Potential Natural Lead Molecule for New Drug Design and Development for the Treatment of Cardiovascular Disorders. Molecules, 27 (3). ISSN 1420-3049
